MDI and DPI Drug Products
...For MDI and DPI drug products, certain studies should be performed to determine.....stability test storage conditions. Additional studies should be performed to characterize.....establish a set of criteria to which a drug substance or drug product should conform using..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)
HUMAN DRUG CGMP NOTES June 1999
...The drug product lot fails the USP test requirement if any microbial growth is found and.....Districts should, as appropriate, consult with respective center program monitors before.....appropriate test procedures designed to assure that drug products conform to appropriate standards of..
http://www.fda.gov/cder/hdn/cnotes69.htm (score=96)
HUMAN DRUG CGMP NOTES, June 1997
...Welcome to another edition of Human Drug CGMP Notes, our periodic memo on CGMP for human.....05 also establishes that in some cases, it may not be necessary for a manufacturer to test.....What regulatory follow up would be appropriate if labeling/copies are required but lacking..
http://www.fda.gov/cder/hdn/cnotes67.htm (score=95)
Fresh Air '2000' A look at FDA's Medical Gas Requirements
...Finally, a finished drug product odor test must be performed on each container undergoing.....These procedures should include appropriate descriptions of the firm's methods of.....This odor test should not be confused with the required prefill odor test, and is required..
http://www.fda.gov/cder/dmpq/freshair.htm (score=94)
þÿ
...Similarly, trials can use several doses of test drug and several doses of an active control.....Each type of control group is appropriate in some circumstances, but none is usable or.....cannot be explained by some characteristic of the study, only superiority of the test drug..
http://www.fda.gov/cder/guidance/4155fnl.pdf (score=92)
Packaging
...In these early stages, the IND should also indicate that appropriate stability studies with the appropriate packaging have been.....A further test to supplement the mouse subchronic systemic test is the procedure for eye.....Arthur Shaw, Food and Drug Administration, for a Course offered by the Center for..
http://www.fda.gov/cder/guidance/package.htm (score=271)
Guidanc for Industry: Container and Closure Integrity Testing in Lieu of...
...test with an appropriate container and closure integrity test in the stability protocol.....microbial barrier, and, hence, the sterility of a drug product throughout its shelf..life.....specific test period or interval, however, the test should be non-destructive and the..
http://www.fda.gov/cber/gdlns/contain.pdf (score=111)
TESTIMONY D. BRUCE BURLINGTON, M.D. (JULY 23, 1998)
...SAMHSA certifies laboratories engaged in employee drug testing for Federal agencies.....Drugs of abuse test sample collection systems typically consist of a collection cup or.....Scientific information is freely shared between the two agencies, with appropriate..
http://www.fda.gov/ola/1998/drugtest.htm (score=111)
stability guidance -draft
...should be assayed for the chemical content of the preservatives at all appropriate test.....include results from microbial challenge studies performed on the drug product at.....and the test methods used to monitor the stability of the drug substance and preliminary..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=101)
GUIDE TO INSPECTIONS OF ORAL SOLID DOSAGE FORMS PRE/POST APPROVAL ISSUES...
...Therefore, the finished dosage form manufacturer must perform the appropriate test to characterize the drug substance.....Therefore, review the specifications, analytical methods, and test results for the lots of the drug substance used to.....drug. Therefore, it is appropriate that the physical characteristics of a drug substance be characterized, that..
http://www.fda.gov/ora/inspect_ref/igs/solid.html (score=97)
þÿ
...ensure that absolutely no one on X drug receives Y drug, FDA believes that a goal, as the.....words, a product is considered safe if it has an appropriate benefit-risk balance for the.....2 For ease of reference, this guidance uses the term product or drug to refer to all drug..
http://www.fda.gov/cder/guidance/5766dft.pdf (score=94)
PET Drug Products … Current Good Manufacturing Practice (CGMP)
...or lot, of a PET drug typically consists of one multiple-dose vial containing the PET drug.....of false-positive results arises in the sampling and transfer of the test aliquot from the.....errors and ensure that appropriate corrective action is taken to prevent their recurrence..
http://www.fda.gov/cder/guidance/4259dft.pdf (score=94)
Draft Guidance for Industry: Development and Use of Risk Minimization Action...
...ensure that absolutely no one on X drug receives Y drug, FDA believes that a goal, as the.....words, a product is considered safe if it has an appropriate benefit-risk balance for the.....2 For ease of reference, this guidance uses the term product or drug to refer to all drug..
http://www.fda.gov/cber/gdlns/riskminim.pdf (score=94)
Guidance for Industry
...product containers, closures, in-process materials, labeling, and drug products conform to appropriate standards of.....deviation is considered to have compromised the integrity of the sterility test, the test.....also require appropriate retesting of any component, drug product container, or closure..
http://www.fda.gov/OHRMS/DOCKETS/98fr/1874dft.pdf (score=94)
...Office of Training and Communication Division of Drug Information, HFD-240 Center for Drug Evaluation and Research Food and.....If you cannot identify the appropriate FDA staff, call the appropriate number listed on.....appropriate test records) prescription only by specially certified health care practitioners product..
http://www.fda.gov/cder/guidance/5766dft.doc (score=94)
Draft Guidance for Industry: Development and Use of Risk Minimization Action...
...Although it might not be possible to ensure that absolutely no one on X drug receives Y drug, FDA believes.....If you cannot identify the appropriate FDA staff, call the appropriate number listed on.....appropriate test records) prescription only by specially certified health care..
http://www.fda.gov/cber/gdlns/riskminim.htm (score=93)
FDA NCI Workshop on Tumor Vaccines
...The multi-drug resistance receptor, 6.. oddly enough, may be involved in the mobilization.....range which might be appropriate for future studies, 8.. and also to get some sense of the.....test the ability of fibrocytes to prime naive T- 18.. cells in vivo, fibrocytes were..
http://www.fda.gov/cber/minutes/tumor121098.pdf (score=93)
FDA/ORA CPG 7132a.16
...Failure to establish scientifically sound and appropriate test procedures for the assay of.....The article is misbranded in that it is regarded as a prescription drug and its labeling.....Failure to test each lot of bulk oxygen to determine conformance with appropriate..
http://www.fda.gov/ora/compliance_ref/cpg/cpgdrg/cpg435-100.html (score=93)
...Office of Training and Communication Division of Drug Information, HFD-240 Center for Drug Evaluation and Research Food and.....If you cannot identify the appropriate FDA staff, call the appropriate number listed on.....appropriate test records) prescription only by specially certified health care practitioners product..
http://www.fda.gov/OHRMS/DOCKETS/98fr/2004d-0188-gdl0001.doc (score=93)
PET Drug Products - Current Good Manufacturing Practice (CGMP)
...Equipment used in the production, processing, or packaging of a PET drug product should be appropriate for the.....The reliability of the supplier's test results can be established by conducting.....When the receiving facility disposes of the recalled drug, the PET drug producer should obtain a signed..
http://www.fda.gov/cder/guidance/4259dft.htm (score=93)
Powered by viXML, providing custom search results
Las Vegas Injury Lawyer